Show simple item record

dc.contributor.authorElera-Fitzcarrald, C.
dc.contributor.authorVega, K.
dc.contributor.authorGamboa-Cárdenas, R.V.
dc.contributor.authorZúñiga, K.
dc.contributor.authorZevallos, F.
dc.contributor.authorReátegui-Sokolova, C.
dc.contributor.authorPastor-Asurza, C.
dc.contributor.authorPerich-Campos, R.
dc.contributor.authorBellido, Z.R.
dc.contributor.authorAranow, C.
dc.contributor.authorAlarcón, G.S.
dc.contributor.authorCalvo, A.
dc.contributor.authorUgarte-Gil, M.F.
dc.date.accessioned2025-10-31T18:35:36Z
dc.date.available2025-10-31T18:35:36Z
dc.date.issued2020
dc.identifier.urihttps://hdl.handle.net/20.500.12805/5304
dc.description.abstractObjective: To determine the reliability of SLE patients' disease activity measurements. Methods: This was a cross-sectional study conducted (August 2016- December 2017) at 2 main public Peruvian hospitals, 1 with a comprehensive lupus care program. Patients assessed their disease activity with a visual analog scale (VAS) (0-100 mm) or a numerical rating scale (NRS) (0-4) before and after their physician's (MD's) assessment. Demographic and disease-related characteristics were recorded. Reliability of patients' disease activity before and after MD's assessment was determined using Spearman rank correlation. Factors possibly associated with this variability were examined with Spearman rank correlation andMann-Whitney U test. Results: Two hundred forty, mostlyMestizo, SLE patients were included; mean (SD) age and disease duration (diagnosis) were 34.9 (12.9) years and 10.1 (7.0) years, respectively. The Mexican version of the Systemic Lupus Erythematosus Disease Activity Index was 1.9 (2.7), and the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index was 1.2 (1.5). The correlations between NRS and VAS before and after the MD's assessment were ρ = 0.839; p < 0.001; and ρ = 0.872; p < 0.001, respectively. Visual analog scale and NRS were higher before than after the MD's assessment (VAS 29.3 [26.5] and 26.5 [24.9], p = 0.052; and NRS (1.5 [1.2] and 1.3 [1.1], p = 0.003); only the comprehensive program explained this variability (p = 0.043). The reliability of VAS and NRS was ρ = 0.917 and ρ = 0.861, p < 0.001, before and after for the comprehensive program and ρ = 0.710 and ρ = 0.785, p < 0.001, for before and after for the regular program. Conclusions: Both VAS an NRS are highly reliable. Patients scored higher before than after their physicians' assessment but that these differences were smaller for the patients in the comprehensive care program than in the regular one.en_US
dc.description.sponsorshipThis work was partially supported by an institutional grant from EsSalud (1483-GCGP-ESSALUD-2013, 1733-GCGP-ESSALUD-2014) and the 2015 Kaelin Prize and one from the Pan American League of Associations for Rheumatology (PANLAR) (2015 PANLAR Prize).
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherLippincott Williams and Wilkins
dc.relation.ispartofurn:issn:1076-1608
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectSystemic Lupus Erythematosus and Patient Outcomesen_US
dc.subjectSystemic Lupus Erythematosus Impact and Managementen_US
dc.titleReliability of Visual Analog Scale and Numeric Rating Scale for the Assessment of Disease Activity in Systemic Lupus Erythematosusen_US
dc.typehttps://purl.org/coar/resource_type/c_2df8fbb1
dc.identifier.doihttps://doi.org/10.1097/RHU.0000000000001274
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.02.17
dc.type.otherResearch article
dc.identifier.journalJournal of Clinical Rheumatology
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2